Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Methaemoglobinaemia secondary to topical lignocaine/prilocaine in a circumcised neonate|
|Citation:||Journal of Paediatrics and Child Health, 2000; 36(4):406-407|
|Publisher:||Blackwell Publishing Asia|
|Abstract:||The use of topical lignocaine/prilocaine (EMLA, Astra Pharmaceuticals, North Ryde, NSW, Australia) for pain relief for neonatal circumcision is becoming more prevalent. Because of immaturity of the methaemoglobin reductase pathway, the neonate is vulnerable to methaemoglobinaemia which is a recognized complication of prilocaine therapy. This is the second report of methaemoglobinaemia due to the use of EMLA in association with circumcision during the newborn period.|
|Keywords:||Humans; Methemoglobinemia; Lidocaine; Prilocaine; Anesthetics, Combined; Anesthetics, Local; Infant, Newborn; Male; Circumcision, Male; Lidocaine, Prilocaine Drug Combination|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.